title: Site of subcutaneous desferrioxamine injection is the initial site of post-transfusion urticaria in multi-transfused beta-thalassaemia major patients.
authors.forename: S
authors.initials: S
authors.lastname: Daar
authors.forename: K
authors.initials: K
authors.lastname: Ghosh
authors.forename: V
authors.initials: V
authors.lastname: Nirmala
mesh_terms: D000293:Adolescent; D000328:Adult; D002614:Chelating Agents / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects; D013156:Splenectomy; D065227:Transfusion Reaction; D014581:Urticaria / Q000139:chemically induced*; D017086:beta-Thalassemia / Q000628:therapy*
chemical_list: D002614:Chelating Agents; D003676:Deferoxamine